Incident Type 2 diabetes and the effect of early regression to normoglycaemia in a population with impaired glucose regulation. Issue 3 (3rd March 2016)

• Record Type: Journal Article
• Authors: Bodicoat, D. H.; Khunti, K.; Srinivasan, B. T.; Mostafa, S.; Gray, L. J.; Davies, M. J.; Webb, D. R.
• Is Part Of: Diabetic medicine. Volume 34:Issue 3(2017)
• Page Start: 396
• Page End: 404
• Publication Date: 2016-03-03
• Subjects: Diabetes -- Periodicals; 616.462
• DOI: 10.1111/dme.13091
• Languages: English
• ISSNs: 0742-3071

Abstract

Abstract: Aims: To report contemporary regression rates from impaired glucose regulation to normal glucose tolerance, identify modifiable factors associated with early regression, and establish whether it affects subsequent diabetes risk in a population‐based cohort. Methods: Participants with impaired glucose regulation (impaired fasting glucose and/or impaired glucose tolerance on a 75‐g oral glucose tolerance test) at baseline in the UK‐based ADDITION‐Leicester study had annual Type 2 diabetes re‐screens for 5 years or until diabetes diagnosis. Logistic regression models investigated modifiable risk factors for regression to normal glucose tolerance at 1 year ( n = 817). Cox regression models estimated subsequent diabetes risk ( n = 630). Results: At 1 year, 54% of participants had regressed to normal glucose tolerance, and 6% had progressed to diabetes. Regression to normal glucose tolerance was associated with weight loss of 0.1–3% [adjusted odds ratio 1.81 (95% CI 1.08, 3.03) compared with maintaining or gaining weight] and a waist circumference reduction of > 3 cm [adjusted odds ratio 1.78 (95% CI 1.03, 3.06) compared with maintaining or increasing waist circumference]. Those with normal glucose tolerance at 1 year subsequently had lower diabetes risk than those who remained with impaired glucose regulation [adjusted hazard ratio 0.19 (95% CI 0.10, 0.37)]. Conclusions: Early regression to normal glucose tolerance was associated with reduced diabetes incidence, and might be induced by small reductions in weight or waist circumference. If confirmed in experimental research, this could be a clear and achievable target for individuals diagnosed with impaired glucose regulation. What's new?: We provide contemporary estimates of the natural history of impaired glucose regulation, which are vital for service planning. Reductions in weight and waist circumference were associated with regression to normal glucose tolerance, which was in turn associated with a much lower subsequent risk of Type 2 diabetes. These data are from a population‐based UK cohort and so are more generalizable than existing data from randomized controlled trials. A message for patients identified with intermediate hyperglycaemia could be that if they lose any weight in the year after diagnosis then they may be almost twice as likely to achieve normal glucose tolerance.